TE
Teva Pharma
TEVA·NYSETel Aviv ILFounded 190137,000 employees
Large CappharmaPublicCNSOncology
Platform: Generic Specialty
Market Cap
$20B
All Drugs
6
Clinical Trials
10
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (TEVA)
Loading TEVA stock data...
Drug Pipeline (6 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| TEV-6161 | TEV-6161 | Preclinical | 1 | PARP | Crohn'sEoE | ||
| Mirisacituzumab | TEV-8040 | Phase 2 | 2 | Aβ | Asthma | ||
| TEV-5361 | TEV-5361 | Preclinical | 2 | MALT1 | RBCTCL | ||
| Rimalucimab | TEV-8712 | Phase 2/3 | 2 | KIF18A | CholangiocarcinomaSCD | ||
| TEV-7734 | TEV-7734 | Approved | 2 | KRASG12C | FLAML | ||
| TEV-8109 | TEV-8109 | Phase 1 | 1 | CD20 | Gastric CaHCC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (8)